跳至主要内容
临床试验/EUCTR2015-005180-16-BG
EUCTR2015-005180-16-BG进行中(未招募)1 期

Early vaginal progesterone for the prevention of spontaneous preterm birth in twins: A randomised, placebo controlled, double-blinded trial. - EVENTS

Fundación para la Formación e Investigación Sanitaria0 个研究点目标入组 1,188 人开始时间: 2018年1月17日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
1,188

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Age > 18 years;
  • DCDA or MCDA twin pregnancies;
  • Live fetuses at 11-13 weeks of gestation;
  • Fluent in local language (otherwise interpreters will be used);
  • Informed and written consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 1188
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • Pregnancies complicated by major fetal abnormality or nuchal translucency thickness >3.5 mm identified at the 11-13 weeks’ scan;
  • MCDA twin pregnancies in which there are early signs of twin-totwin
  • transfusion syndrome (TTTS), defined as 20% discordance in
  • crown-rump length (CRL) at the 11-13 weeks scan;
  • Women who are unconscious or severely ill, those with learning
  • difficulties, or serious mental illness;
  • Hypersensitivity to progesterone;
  • Women taking progesterone at any time within the previous 7 days;
  • Participation in another drug trial at any time within the previous 28
  • Severe hepatic dysfunction [AST or ALT >3 times the upper limit of
  • normal (ULN) or bilirubin >2 x ULN], mammary or genital tract
  • carcinoma, thrombophlebitis or thromboembolic disorders
  • Porphyria
  • Cerebral haemorrhage
  • Allergy to sunflower oil, soy lethicin, gelatin, glycerol (E422),
  • titanium dioxide (E171)

研究者

发起方
Fundación para la Formación e Investigación Sanitaria

相似试验